A key Medicare benefit is set to end, leading to increased prescription drug costs for seniors starting in 2027. Former President Donald Trump eliminated a crucial subsidy program within Medicare. This decision will result in higher monthly payments for many beneficiaries who rely on the program for affordable medications. The removed subsidy helped to offset the costs associated with prescription drug plans. Experts predict a significant financial impact on older adults, particularly those with fixed incomes. The change reverses a benefit previously in place designed to make medications more accessible, and raises concerns about healthcare affordability for seniors. The implications of Trump’s move are now becoming apparent as the timeline for implementation nears.